Ovid Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ovid Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Ovid Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 71M shares, a 0.51% increase year-over-year.
  • Ovid Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 70.6M shares, a 0.22% increase from 2022.
  • Ovid Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 70.4M shares, a 4.37% increase from 2021.
  • Ovid Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 67.5M shares, a 15.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 71M +357K +0.51% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 70.9M +382K +0.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 70.7M +226K +0.32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 70.6M +156K +0.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 70.6M +188K +0.27% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 70.5M +143K +0.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 70.5M +145K +0.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 70.4M +2.95M +4.37% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 70.4M +2.5M +3.68% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 70.4M +2.57M +3.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 70.3M +4.26M +6.44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 67.5M +9.03M +15.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 67.9M +8.52M +14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 67.8M +12.2M +22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 66.1M +11.4M +20.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 58.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 59.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 55.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 54.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.